G9611 HCPCS Reimbursement & Policy Benchmarks | OpenPayer

Summary & Overview

HCPCS G9611: Order for Antiplatelet Agents Not Documented

HCPCS Level II code G9611 flags instances when an order for antiplatelet agents is missing from the patient record with no documented reason. As a documentation-centered code, it matters nationally for quality reporting, medication reconciliation, and post-procedure safety monitoring, particularly in populations at risk for thrombotic events. Proper use of G9611 helps payers and providers identify gaps in prescribing or documentation that could affect patient safety and care coordination. Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find an overview of the code meaning and clinical context, discussion of typical sites of service where the code applies (inpatient, outpatient clinic, emergency department, and post-procedure care), and what to expect in benchmarking and administrative reporting. The publication covers how G9611 is used in documentation and quality workflows, common modifiers reported with medication-order codes (list provided separately), and notes on missing input fields where applicable. Data not available in the input are explicitly indicated where relevant. The intent is to furnish administrators, coders, and policy analysts with a concise reference to inform documentation review, quality measurement, and payer communications at a national level.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9611HCPCS Level IIantiplateletmedication reconciliationquality measuredocumentationinpatient careoutpatient clinicemergency department

Billing Code Overview

HCPCS Level II code G9611 indicates that an order for anti-platelet agents was not documented in the patient's record, reason not given. This code describes a documentation gap regarding antiplatelet therapy orders following a clinical encounter.

Service type: Medication order documentation / care quality measure related to antiplatelet therapy

Typical site of service: Inpatient hospital or outpatient clinic setting where antiplatelet therapy would be prescribed or reconciled, including emergency department and post-procedure care settings

Clinical & Coding Specifications

Clinical Context

A typical patient scenario involves an adult admitted with acute ischemic stroke or transient ischemic attack (TIA) for whom initiation of antiplatelet therapy is a standard element of secondary prevention. The clinical workflow begins with emergency department evaluation, neuroimaging (CT or MRI) to exclude hemorrhage, and neurology consultation. Once ischemic stroke or TIA is confirmed and no contraindication (e.g., active bleeding, need for emergent surgery) exists, an order for antiplatelet therapy (such as aspirin or clopidogrel) is expected to be documented in the inpatient medication administration record or discharge orders. The billing code G9611 is applied when the patient’s record lacks documentation of an order for antiplatelet agents and no reason for omission is recorded. Typical site of service is the inpatient hospital setting, including observation status and emergency department encounters leading to admission. Typical patient characteristics include adults with recent ischemic cerebral events, often with vascular risk factors such as hypertension, diabetes, atrial atherosclerosis, or prior stroke. Documentation workflow touches emergency physicians, hospitalists, neurologists, pharmacists, and nursing staff responsible for medication reconciliation and order entry.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	When extensive additional work or complexity related to care coordination or documentation must be reported (use sparingly and per payer rules).

HCPCS G9987: BPCI Advanced Home Visit Patient Assessment

HCPCS-G2186-PATIENT-CAREGIVER-RESOURCE-REFERRAL-CONFIRMATION

HCPCS G2186: Patient/Caregiver Resource Referral and Confirmation

HCPCS-G9709-HOSPICE-SERVICES-MEASUREMENT-PERIOD

HCPCS G9709: Hospice Services During Measurement Period

HCPCS-G0914-PATIENT-SURVEY-NOT-COMPLETED

HCPCS G0914: Patient Care Survey Not Completed by Patient

HCPCS-G9152-COMMUNITY-HEALTH-TEAM-DEMONSTRATION

HCPCS G9152: Community Health Team Demonstration

HCPCS-G6049-EPIANDROSTERONE-LABORATORY-AGENT

HCPCS G6049: Epiandrosterone Laboratory/Administration

HCPCS-G4006-GASTROENTEROLOGY-MIPS-SPECIALTY-SET

HCPCS G4006: Gastroenterology MIPS Specialty Set

HCPCS-G1003-CLINICAL-DECISION-SUPPORT-APPROPRIATE-USE

HCPCS G1003: Clinical Decision Support Mechanism for Appropriate Use Criteria

HCPCS-G0085-EXTENSIVE-CARE-MANAGEMENT-HOME-VISIT-75MIN

HCPCS G0085: Extensive Care Management Home Visit, 75 Minutes

HCPCS-G8430-MEDICAL-REASON-FOR-NOT-DOCUMENTING-MEDICATION-LIST

HCPCS G8430: Medical Reason for Not Documenting Medication List

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`2084P0800X`	Neurology	Neurologists commonly evaluate stroke/TIA patients and recommend antiplatelet therapy.
`208D00000X`	Internal Medicine	Hospitalists and internists frequently manage inpatient stroke care and medication reconciliation.
`207Q00000X`	Emergency Medicine	Emergency physicians perform initial stroke assessment and order acute therapies.
`363L00000X`	Pharmacy	Clinical pharmacists review medication orders, contraindications, and reconciliation.
`372C00000X`	Vascular Medicine	Vascular specialists may be involved when cerebrovascular atherosclerotic disease guides antiplatelet strategy.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I63.9`	Cerebral infarction, unspecified	Ischemic stroke diagnosis for which antiplatelet therapy is a standard secondary prevention measure.
`G45.9`	Transient cerebral ischemic attack, unspecified	TIA management commonly includes antiplatelet initiation to reduce recurrent stroke risk.
`I66.9`	Occlusion and stenosis of cerebral arteries, unspecified	Large- or small-vessel cerebrovascular disease where antiplatelet therapy may be indicated.
`I67.89`	Other cerebrovascular disease	Chronic cerebrovascular conditions that influence antiplatelet use for prevention.
`I74.9`	Arterial embolism and thrombosis of unspecified site	Embolic events that may prompt antiplatelet or anticoagulant decision-making; documentation of antiplatelet orders is relevant.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99223`	Initial hospital care, typically 70 minutes or more	Admission evaluation by a physician for an acute stroke patient prior to establishing medication orders, including antiplatelet therapy.
`99285`	Emergency department visit, high complexity	Emergency department evaluation of a patient with suspected stroke where antiplatelet orders should be considered after imaging excludes hemorrhage.
`70336`	CT angiography, head or neck (single area)	Imaging often performed early to evaluate vascular occlusion or stenosis that influences antiplatelet decisions.
`70553`	MRI brain with and without contrast	Advanced neuroimaging to confirm ischemia and guide secondary prevention including antiplatelet therapy.
`99143`	Moderate sedation services provided by the physician (example code)	Procedures requiring sedation (e.g., endovascular interventions) that may affect timing of antiplatelet initiation.

OpenPayer